Y-Intercept (HK)’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
CAM
CCM
Y-Intercept (HK)'s LMAT Position: Q2 2026 in Review
Y-Intercept (HK) opened a new position in LeMaitre Vascular (LMAT) in Q2 2026: 20,871 shares worth $2M. The stake represents 0.04% of the portfolio and ranks #701 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in LMAT as recently as Q4 2025.
Y-Intercept (HK) first reported a position in LMAT in Q1 2024 and has held it in 4 quarters since. The position peaked at $2.25M in Q4 2025. 327 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.
- Y-Intercept (HK) held 20,871 shares of LeMaitre Vascular worth $2M as of Q2 2026.
- LeMaitre Vascular was a new Y-Intercept (HK) position in Q2 2026.
- LeMaitre Vascular made up 0.04% of Y-Intercept (HK)'s portfolio in Q2 2026, its #701 holding.
- Y-Intercept (HK) first reported a position in LeMaitre Vascular in Q1 2024 and has held it in 4 quarters since.
- Y-Intercept (HK)'s LeMaitre Vascular position peaked at $2.25M in Q4 2025.
- 327 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.
Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.